BIOS VS XYF Stock Comparison

Performance

BIOS
100/100

BIOS returned 7.25% in the last 12 months. Based on SPY's performance of -3.02%, its performance is above average giving it a score of 100 of 100.

XYF
100/100

XYF returned 88.99% in the last 12 months. Based on SPY's performance of 9.73%, its performance is above average giving it a score of 100 of 100.

Analyst Price Targets

BIOS
88/100

6 analysts offer 12-month price targets for BIOS. Together, they have an average target of 0, the most optimistic target put BIOS at 0 within 12-months and the most pessimistic has BIOS at 0. These analyst ratings are from our partners at Financial Modeling Prep and Alpha Vantage.

XYF
50/100

2 analysts offer 12-month price targets for XYF. Together, they have an average target of 0, the most optimistic target put XYF at 0 within 12-months and the most pessimistic has XYF at 0.

Profit

BIOS
12/100

Out of the last 20 quarters, BIOS has had 4 profitable quarters and has increased their profits year over year on 0 of them.

XYF
64/100

Out of the last 20 quarters, XYF has had 16 profitable quarters and has increased their profits year over year on 7 of them.

Volatility

BIOS
10/100

BIOS has had a lower than average amount of volatility over the last 12 months giving it a score of 10 of 100.

XYF
63/100

XYF has had a higher than average amount of volatility over the last 12 months giving it a score of 62 of 100.

Sentiment

BIOS

"Sentiment" not found for BIOS

XYF
0/100

XYF had a bearish sentiment score of 0.00% across Twitter and StockTwits over the last 12 months. It had an average of 1.00 posts, 0.00 comments, and 0.50 likes per day.

Technicals

BIOS

"Technicals" not found for BIOS

XYF
82/100

XYF receives a 82 of 100 based on 14 indicators. 11 are bullish, 2 are bearish.

Earnings

BIOS

"Earnings" not found for BIOS

XYF
100/100

XYF has missed earnings 1 times in the last 20 quarters.

All score calculations are broken down here to help you make more informed investing decisions

BioPlus Acquisition Corp. Class A Ordinary Shares Summary

Nasdaq / BIOS

Financial Services

Shell Companies

BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.

X Financial American Depositary Shares, each representing six Class A Ordinary Shares Summary

New York Stock Exchange / XYF

Financial Services

Financial - Credit Services

X Financial provides personal finance services in the People's Republic of China. The company offers services as an online marketplace connecting borrowers and investors. Its loan products include Xiaoying credit loan, which consists of Xiaoying card loan; and Xiaoying preferred loan to small business owners, as well as Xiaoying revolving loan. The company also offers Xiaoying housing loan, a home equity loan product for property owners; investment products through Xiaoying wealth management platform, such as loans, money market, and insurance products; and loan facilitation services to other platforms. X Financial was founded in 2014 and is headquartered in Shenzhen, the People's Republic of China.

Power up your portfolio